Both heart failure and coronary heart disease appear to be important underlying conditions in the pathophysiology of cardiorenal syndrome, according to investigators.
In a study, older hemodialysis patients performing resistance exercise for 24 weeks saw their iron bioavailability increase.
First patient-driven study of the impact of various prostate cancer treatments documents differences in the effects of radical prostatectomy, radiation therapy, and chemotherapy.
For patients with chronic kidney disease (CKD) receiving erythropoiesis-stimulating agents (ESAs), achieving hemoglobin (Hb) levels higher than guideline-recommended target range is associated with a small but potentially clinically significant improvement in fatigue, although not in the ability to perform usual daily work or other activities. In a systematic review and meta-analysis of 15 randomized trials…
In a randomized trial, investigators observed no significant survival difference between acute kidney injury patients who did and did not initiate renal replacement therapy within 12 hours.
Early results from the phase 3 FIDELIO-DKD study also show that finerenone reduces the risk for a cardiovascular secondary endpoint in patients with diabetic kidney disease.